TY - JOUR
T1 - The safe passage study
T2 - Design, methods, recruitment, and follow-up approach
AU - PASS Research Network
AU - Dukes, Kimberly A.
AU - Burd, Larry
AU - Elliott, Amy J.
AU - Fifer, William P.
AU - Folkerth, Rebecca D.
AU - Hankins, Gary D.V.
AU - Hereld, Dale
AU - Hoffman, Howard J.
AU - Myers, Michael M.
AU - Odendaal, Hein J.
AU - Signore, Caroline
AU - Sullivan, Lisa M.
AU - Willinger, Marian
AU - Wright, Colleen
AU - Kinney, Hannah C.
N1 - Publisher Copyright:
© 2014 John Wiley & Sons Ltd.
PY - 2014
Y1 - 2014
N2 - Background: The Safe Passage Study is a large, prospective, multidisciplinary study designed to (1) investigate the association between prenatal alcohol exposure, sudden infant death syndrome (SIDS), and stillbirth, and (2) determine the biological basis of the spectrum of phenotypic outcomes from exposure, as modified by environmental and genetic factors that increase the risk of stillbirth, SIDS, and in surviving children, fetal alcohol spectrum disorders. Methods: The results provided are based on an interim assessment of 6004 women enrolled, out of the 12 000 projected, from the Northern Plains, US, and Cape Town, South Africa, areas known to be of high risk for maternal drinking during pregnancy. Research objectives, study design, and descriptive statistics, including consent, recruitment, and retention information, are provided. Results: Overall visit compliance is 87%, and includes prenatal, delivery/newborn, and postnatal contacts through 1 year post-delivery. Pregnancy outcome ascertainment is 98% prior to medical chart review; less than 2% of women withdraw. Consent for the use of DNA and placental tissueexceed 94%, and consent to participate in the autopsy portion of the study is 71%. Conclusions: The Safe Passage Study is the first multi-site study of SIDS and stillbirth to integrate prospectively collected exposure information with multidisciplinary biological information in the same maternal and fetal/ infant dyad using a common protocol. Essential components of the study design and its success are close ties to the community and rigorous systems and processes to ensure compliance with the study protocol and procedures.
AB - Background: The Safe Passage Study is a large, prospective, multidisciplinary study designed to (1) investigate the association between prenatal alcohol exposure, sudden infant death syndrome (SIDS), and stillbirth, and (2) determine the biological basis of the spectrum of phenotypic outcomes from exposure, as modified by environmental and genetic factors that increase the risk of stillbirth, SIDS, and in surviving children, fetal alcohol spectrum disorders. Methods: The results provided are based on an interim assessment of 6004 women enrolled, out of the 12 000 projected, from the Northern Plains, US, and Cape Town, South Africa, areas known to be of high risk for maternal drinking during pregnancy. Research objectives, study design, and descriptive statistics, including consent, recruitment, and retention information, are provided. Results: Overall visit compliance is 87%, and includes prenatal, delivery/newborn, and postnatal contacts through 1 year post-delivery. Pregnancy outcome ascertainment is 98% prior to medical chart review; less than 2% of women withdraw. Consent for the use of DNA and placental tissueexceed 94%, and consent to participate in the autopsy portion of the study is 71%. Conclusions: The Safe Passage Study is the first multi-site study of SIDS and stillbirth to integrate prospectively collected exposure information with multidisciplinary biological information in the same maternal and fetal/ infant dyad using a common protocol. Essential components of the study design and its success are close ties to the community and rigorous systems and processes to ensure compliance with the study protocol and procedures.
KW - Fetal alcohol spectrum disorders
KW - PASS
KW - Prenatal alcohol exposure
KW - Safe Passage Study
KW - Stillbirth
KW - Study methodology
KW - Sudden infant death syndrome
UR - http://www.scopus.com/inward/record.url?scp=84927788425&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84927788425&partnerID=8YFLogxK
U2 - 10.1111/ppe.12136
DO - 10.1111/ppe.12136
M3 - Article
C2 - 25131605
AN - SCOPUS:84927788425
SN - 0269-5022
VL - 28
SP - 455
EP - 465
JO - Paediatric and Perinatal Epidemiology
JF - Paediatric and Perinatal Epidemiology
IS - 5
ER -